IBA develops and markets technologies, pharmaceutical products, and tailored solutions for the healthcare sector, with a focus on cancer diagnosis and therapy. They are also involved in industrial sterilization and ionization. The company operates through two business segments: pharmaceuticals, which includes radiopharmaceuticals, and equipment, which encompasses proton therapy, particle accelerators, and dosimetry. With approximately 1,600 employees worldwide, IBA is a certified B Corporation, meeting high standards of social and environmental performance.